Zobrazeno 1 - 10
of 135
pro vyhledávání: '"Birger Thorsteinsson"'
Autor:
Sofie Broeng-Mikkelgaard, Julie Maria Bøggild Brøsen, Peter Lommer Kristensen, Birger Thorsteinsson, Ulrik Pedersen-Bjergaard
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Type 1 diabetes is characterized by insulin deficiency, and treatment is to supply insulin mimicking the physiological endogenous insulin secretion. Since its discovery, insulin therapy has evolved, and since the 1990s, an increasing number of insuli
Externí odkaz:
https://doaj.org/article/f13ed68e0b504461bf384dd42842a704
Autor:
Christian Stevns Hansen, Louise Lundby-Christiansen, Lise Tarnow, Christian Gluud, Christoffer Hedetoft, Birger Thorsteinsson, Bianca Hemmingsen, Niels Wiinberg, Simone B. Sneppen, Søren S. Lund, Thure Krarup, Sten Madsbad, Thomas Almdal, Bendix Carstensen, Marit E. Jørgensen, the CIMT study group
Publikováno v:
Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-10 (2020)
Abstract Background Metformin has been shown to have both neuroprotective and neurodegenerative effects. The aim of this study was to investigate the effect of metformin in combination with insulin on cardiovascular autonomic neuropathy (CAN) and dis
Externí odkaz:
https://doaj.org/article/6cde7852a4314b588757a999c744f536
Autor:
Carina Kirstine Klarskov, Elena von Rohden, Birger Thorsteinsson, Lise Tarnow, Peter Lommer Kristensen
Publikováno v:
Endocrinology, Diabetes & Metabolism, Vol 4, Iss 4, Pp n/a-n/a (2021)
Abstract Objective Gustatory sweating (GS) is characterized by profuse sweating during or immediately after ingestion of food and is known as a complication of diabetes mellitus (DM). This study aimed to determine the prevalence of GS and to characte
Externí odkaz:
https://doaj.org/article/5e87f39b36084a8f951763c1802000bd
Autor:
Rikke Mette Agesen, Amra Ciric Alibegovic, Henrik Ullits Andersen, Henning Beck-Nielsen, Peter Gustenhoff, Troels Krarup Hansen, Christoffer Hedetoft, Tonny Jensen, Claus Bogh Juhl, Susanne Søgaard Lerche, Kirsten Nørgaard, Hans-Henrik Parving, Lise Tarnow, Birger Thorsteinsson, Ulrik Pedersen-Bjergaard
Publikováno v:
BMC Endocrine Disorders, Vol 19, Iss 1, Pp 1-8 (2019)
Abstract Background Hypoglycaemia, especially nocturnal, remains the main limiting factor of achieving good glycaemic control in type 1 diabetes. The effect of first generation long-acting insulin analogues in reducing nocturnal hypoglycaemia is well
Externí odkaz:
https://doaj.org/article/56c340efa21f4ca096ea9c50af1669e9
Autor:
Anne Margareta Banghøj, Christoffer Krogager, Peter Lommer Kristensen, Klavs Würgler Hansen, Esben Laugesen, Jesper Fleischer, Simon Lebech Cichosz, Per Løgstrup Poulsen, Martin Glymer Kirkegaard, Birger Thorsteinsson, Lise Tarnow
Publikováno v:
Endocrinology, Diabetes & Metabolism, Vol 4, Iss 2, Pp n/a-n/a (2021)
Abstract Aim Obstructive sleep apnoea (OSA) is frequent in type 2 diabetes (T2D). The aim was to investigate the effect of a 12‐week treatment with continuous positive airway pressure (CPAP) on glycaemic control assessed by continuous glucose monit
Externí odkaz:
https://doaj.org/article/a86a4e9c8e8941ffb0d3d70d0f2c4813
Autor:
Peter L Kristensen, Ulrik Pedersen-Bjergaard, Rikke Due-Andersen, Thomas Høi-Hansen, Lise Grimmeshave, Valeriya Lyssenko, Leif Groop, Jens J Holst, Allan A Vaag, Birger Thorsteinsson
Publikováno v:
Endocrinology, Diabetes & Metabolism Case Reports, Vol 5, Iss 6, Pp 53-60 (2016)
Introduction: In healthy carriers of the T allele of the transcription factor 7-like 2 (TCF7L2), fasting plasma glucagon concentrations are lower compared with those with the C allele. We hypothesised that presence of the T allele is associated with
Externí odkaz:
https://doaj.org/article/4f2304c7386042179acd00d1b9af462f
Autor:
Peter Lommer Kristensen, Ulrik Pedersen-Bjergaard, Troels Wesenberg Kjær, Niels Vidiendal Olsen, Flemming Dela, Jens Juul Holst, Jens Faber, Lise Tarnow, Birger Thorsteinsson
Publikováno v:
PLoS ONE, Vol 8, Iss 4, p e59672 (2013)
The incidence of severe hypoglycemia in type 1 diabetes has not decreased over the past decades. New treatment modalities minimizing the risk of hypoglycemic episodes and attenuating hypoglycemic cognitive dysfunction are needed. We studied if treatm
Externí odkaz:
https://doaj.org/article/2f49d5dd990646aa953ff12a577035b1
Autor:
Julie Maria Bøggild Brøsen, Rikke Mette Agesen, Amra Ciric Alibegovic, Henrik Ullits Andersen, Henning Beck-Nielsen, Peter Gustenhoff, Troels Krarup Hansen, Christoffer Georg Riber Hedetoft, Tonny Joran Jensen, Charlotte Røn Stolberg, Claus Bogh Juhl, Susanne Søgaard Lerche, Kirsten Nørgaard, Hans-Henrik Parving, Lise Tarnow, Birger Thorsteinsson, Ulrik Pedersen-Bjergaard
Publikováno v:
Brøsen, J M B, Agesen, R M, Alibegovic, A C, Andersen, H U, Beck-Nielsen, H, Gustenhoff, P, Hansen, T K, Hedetoft, C G R, Jensen, T J, Stolberg, C R, Juhl, C B, Lerche, S S, Nørgaard, K, Parving, H-H, Tarnow, L, Thorsteinsson, B & Pedersen-Bjergaard, U 2022, ' Continuous Glucose Monitoring-Recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia ', Diabetes Technology & Therapeutics, vol. 24, no. 9, pp. 643-654 . https://doi.org/10.1089/dia.2021.0567
Brøsen, J M B, Agesen, R M, Alibegovic, A C, Ullits Andersen, H, Beck-Nielsen, H, Gustenhoff, P, Krarup Hansen, T, Hedetoft, C G R, Jensen, T J, Stolberg, C R, Bogh Juhl, C, Lerche, S S, Nørgaard, K, Parving, H H, Tarnow, L, Thorsteinsson, B & Pedersen-Bjergaard, U 2022, ' Continuous Glucose Monitoring-Recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia ', Diabetes Technology & Therapeutics, vol. 24, no. 9, pp. 643-654 . https://doi.org/10.1089/dia.2021.0567
Brøsen, J M B, Agesen, R M, Alibegovic, A C, Ullits Andersen, H, Beck-Nielsen, H, Gustenhoff, P, Krarup Hansen, T, Hedetoft, C G R, Jensen, T J, Stolberg, C R, Bogh Juhl, C, Lerche, S S, Nørgaard, K, Parving, H H, Tarnow, L, Thorsteinsson, B & Pedersen-Bjergaard, U 2022, ' Continuous Glucose Monitoring-Recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia ', Diabetes Technology & Therapeutics, vol. 24, no. 9, pp. 643-654 . https://doi.org/10.1089/dia.2021.0567
Background and Aims: Nocturnal hypoglycemia is mainly a consequence of inappropriate basal insulin therapy in type 1 diabetes (T1D) and may compromise optimal glycemic control. Insulin degludec is associated with a lower risk of nocturnal hypoglycemi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83477b07b58cfa9237757d8626ffbdc9
https://doi.org/10.1089/dia.2021.0567
https://doi.org/10.1089/dia.2021.0567
Autor:
Julie Maria Bøggild Brøsen, Rikke Mette Agesen, Peter Lommer Kristensen, Amra Ciric Alibegovic, Henrik Ullits Andersen, Henning Beck‐Nielsen, Peter Gustenhoff, Troels Krarup Hansen, Christoffer Hedetoft, Tonny Jensen, Charlotte Røn Stolberg, Claus Bogh Juhl, Susanne Søgaard Lerche, Kirsten Nørgaard, Hans‐Henrik Parving, Lise Tarnow, Birger Thorsteinsson, Ulrik Pedersen‐Bjergaard
Publikováno v:
Brøsen, J M B, Agesen, R M, Kristensen, P L, Alibegovic, A C, Andersen, H U, Beck-Nielsen, H, Gustenhoff, P, Hansen, T K, Hedetoft, C, Jensen, T, Stolberg, C R, Juhl, C B, Lerche, S S, Nørgaard, K, Parving, H-H, Tarnow, L, Thorsteinsson, B & Pedersen-Bjergaard, U 2023, ' Effect of insulin degludec versus insulin glargine U100 on nocturnal glycaemia assessed by plasma glucose profiles in people with type 1 diabetes prone to nocturnal severe hypoglycaemia ', Diabetes, Obesity and Metabolism, vol. 25, no. 6, pp. 1557-1565 . https://doi.org/10.1111/dom.15003
Brøsen, J M B, Agesen, R M, Kristensen, P L, Alibegovic, A C, Andersen, H U, Beck-Nielsen, H, Gustenhoff, P, Hansen, T K, Hedetoft, C, Jensen, T, Stolberg, C R, Juhl, C B, Lerche, S S, Nørgaard, K, Parving, H H, Tarnow, L, Thorsteinsson, B & Pedersen-Bjergaard, U 2023, ' Effect of insulin degludec versus insulin glargine U100 on nocturnal glycaemia assessed by plasma glucose profiles in people with type 1 diabetes prone to nocturnal severe hypoglycaemia ', Diabetes, Obesity and Metabolism, vol. 25, no. 6, pp. 1557-1565 . https://doi.org/10.1111/dom.15003
Brøsen, J M B, Agesen, R M, Kristensen, P L, Alibegovic, A C, Andersen, H U, Beck-Nielsen, H, Gustenhoff, P, Hansen, T K, Hedetoft, C, Jensen, T, Stolberg, C R, Juhl, C B, Lerche, S S, Nørgaard, K, Parving, H H, Tarnow, L, Thorsteinsson, B & Pedersen-Bjergaard, U 2023, ' Effect of insulin degludec versus insulin glargine U100 on nocturnal glycaemia assessed by plasma glucose profiles in people with type 1 diabetes prone to nocturnal severe hypoglycaemia ', Diabetes, Obesity and Metabolism, vol. 25, no. 6, pp. 1557-1565 . https://doi.org/10.1111/dom.15003
AimTo compare nocturnal glucose profiles according to hourly plasma glucose measurements during treatment with insulin degludec and insulin glargine U100 in a cohort of people with type 1 diabetes prone to nocturnal severe hypoglycaemia.Materials and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d07099b522b8b06a592ab8b2f03b35f9
https://vbn.aau.dk/da/publications/c728821a-6d2a-4051-b5bf-3b6ae4088b70
https://vbn.aau.dk/da/publications/c728821a-6d2a-4051-b5bf-3b6ae4088b70
Autor:
Kim Z. Rokamp, Flemming Dela, Niels H. Secher, Lars Grønlykke, Birger Thorsteinsson, Ulrik Pedersen-Bjergaard
The β2-receptor mediates the metabolic response to epinephrine. This study investigates the impact of the β2-receptor gene (ADRB2) polymorphism Gly16Arg on the metabolic response to epinephrine before and after repetitive hypoglycemia. Twenty-five
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40948bd95320b102dd7e85d38072bfd3
https://doi.org/10.2337/figshare.22242586
https://doi.org/10.2337/figshare.22242586